Literature DB >> 12666121

Continuous growth of mean tumor diameter in a subset of grade II gliomas.

Emmanuel Mandonnet1, Jean-Yves Delattre, Marie-Laure Tanguy, Kristin R Swanson, Antoine F Carpentier, Hugues Duffau, Philippe Cornu, Rémy Van Effenterre, Ellsworth C Alvord, Laurent Capelle.   

Abstract

Serial magnetic resonance images of 27 patients with untreated World Health Organization grade II oligodendrogliomas or mixed gliomas were reviewed retrospectively to study the kinetics of tumor growth before anaplastic transformation. Analysis of the mean tumor diameters over time showed constant growth. Linear regression, using a mixed model, found an average slope of 4.1mm per year (95% confidence interval, 3.8-4.4mm/year). Untreated low-grade oligodendrogliomas or mixed gliomas grow continuously during their premalignant phase, and their pattern of growth can be predicted within a relatively narrow range. These findings could be of interest to optimize patients management and follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 12666121     DOI: 10.1002/ana.10528

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  122 in total

1.  Improving the time-machine: estimating date of birth of grade II gliomas.

Authors:  C Gerin; J Pallud; B Grammaticos; E Mandonnet; C Deroulers; P Varlet; L Capelle; L Taillandier; L Bauchet; H Duffau; M Badoual
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Dynamic imaging response following radiation therapy predicts long-term outcomes for diffuse low-grade gliomas.

Authors:  Johan Pallud; Jean-François Llitjos; Frédéric Dhermain; Pascale Varlet; Edouard Dezamis; Bertrand Devaux; Raphaëlle Souillard-Scémama; Nader Sanai; Maria Koziak; Philippe Page; Michel Schlienger; Catherine Daumas-Duport; Jean-François Meder; Catherine Oppenheim; François-Xavier Roux
Journal:  Neuro Oncol       Date:  2012-03-13       Impact factor: 12.300

3.  Complete recovery after surgical resection of left Wernicke's area in awake patient: a brain stimulation and functional MRI study.

Authors:  Silvio Sarubbo; Emmanuelle Le Bars; Sylvie Moritz-Gasser; Hugues Duffau
Journal:  Neurosurg Rev       Date:  2011-09-27       Impact factor: 3.042

4.  Prolonged response without prolonged chemotherapy: a lesson from PCV chemotherapy in low-grade gliomas.

Authors:  Matthieu Peyre; Stéphanie Cartalat-Carel; David Meyronet; Damien Ricard; Anne Jouvet; Johan Pallud; Karima Mokhtari; Jacques Guyotat; Emmanuel Jouanneau; Marie-Pierre Sunyach; Didier Frappaz; Jérôme Honnorat; François Ducray
Journal:  Neuro Oncol       Date:  2010-05-20       Impact factor: 12.300

5.  Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment.

Authors:  Raymond Y Huang; Robert J Young; Benjamin M Ellingson; Harini Veeraraghavan; Wei Wang; Florent Tixier; Hyemin Um; Rasheed Nawaz; Tracy Luks; John Kim; Elizabeth R Gerstner; David Schiff; Katherine B Peters; Ingo K Mellinghoff; Susan M Chang; Timothy F Cloughesy; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

6.  Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas.

Authors:  Dan Ribom; Marjoleine Schoenmaekers; Henry Engler; Anja Smits
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

Review 7.  Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.

Authors:  Leif-Erik Bohman; Kristin R Swanson; Julia L Moore; Russ Rockne; Christopher Mandigo; Todd Hankinson; Marcela Assanah; Peter Canoll; Jeffrey N Bruce
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

8.  IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.

Authors:  Amélie Darlix; Jérémy Deverdun; Nicolas Menjot de Champfleur; Florence Castan; Sonia Zouaoui; Valérie Rigau; Michel Fabbro; Yordanka Yordanova; Emmanuelle Le Bars; Luc Bauchet; Catherine Gozé; Hugues Duffau
Journal:  J Neurooncol       Date:  2017-04-22       Impact factor: 4.130

9.  X-ray induced photodynamic therapy with copper-cysteamine nanoparticles in mice tumors.

Authors:  Samana Shrestha; Jing Wu; Bindeshwar Sah; Adam Vanasse; Leon N Cooper; Lun Ma; Gen Li; Huibin Zheng; Wei Chen; Michael P Antosh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

10.  A mathematical model for brain tumor response to radiation therapy.

Authors:  R Rockne; E C Alvord; J K Rockhill; K R Swanson
Journal:  J Math Biol       Date:  2008-09-25       Impact factor: 2.259

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.